Copyright Reports & Markets. All rights reserved.

USA Bio-pharma Market Report 2018

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Definition and Specification
    • 1.2 Report Overview
      • 1.2.1 Manufacturers Overview
      • 1.2.2 Regions Overview
      • 1.2.3 Type Overview
      • 1.2.4 Application Overview
    • 1.3 Industrial Chain
      • 1.3.1 Bio-pharma Overall Industrial Chain
      • 1.3.2 Upstream
      • 1.3.3 Downstream
    • 1.4 Industry Situation
      • 1.4.1 Industrial Policy
      • 1.4.2 Product Preference
      • 1.4.3 Economic/Political Environment
    • 1.5 SWOT Analysis

    2 Market Analysis by Types

    • 2.1 Overall Market Performance(Volume)
      • 2.1.1 Monoclonal Antibodies Market Performance (Volume)
      • 2.1.2 Recombinant Proteins Market Performance (Volume)
      • 2.1.3 Granulocyte-Colony Stimulating Factor (G-CSF) Market Performance (Volume)
      • 2.1.4 Interferons Market Performance (Volume)
      • 2.1.5 Recombinant Human Insulin Market Performance (Volume)
    • 2.2 Overall Market Performance(Value)
      • 2.1.1 Monoclonal Antibodies Market Performance (Value)
      • 2.1.2 Recombinant Proteins Market Performance (Value)
      • 2.1.3 Granulocyte-Colony Stimulating Factor (G-CSF) Market Performance (Value)
      • 2.1.4 Interferons Market Performance (Value)
      • 2.1.5 Recombinant Human Insulin Market Performance (Value)

    3 Product Application Market

    • 3.1 Overall Market Performance (Volume)
      • 3.1.1 Metabolic Disorders Market Performance (Volume)
      • 3.1.2 Oncology Market Performance (Volume)
      • 3.1.3 Neurological Disorders Market Performance (Volume)
      • 3.1.4 Cardiovascular Diseases Market Performance (Volume)
      • 3.1.5 Inflammatory and Infectious Diseases Market Performance (Volume)
      • 3.1.6 Others Market Performance (Volume)

    4 Manufacturers Profiles/Analysis

    • 4.1 Pfizer
      • 4.1.1 Pfizer Profiles
      • 4.1.2 Pfizer Product Information
      • 4.1.3 Pfizer Bio-pharma Business Performance
      • 4.1.4 Pfizer Bio-pharma Business Development and Market Status
    • 4.2 F. Hoffmann-La Roche AG
      • 4.2.1 F. Hoffmann-La Roche AG Profiles
      • 4.2.2 F. Hoffmann-La Roche AG Product Information
      • 4.2.3 F. Hoffmann-La Roche AG Bio-pharma Business Performance
      • 4.2.4 F. Hoffmann-La Roche AG Bio-pharma Business Development and Market Status
    • 4.3 Johnson & Johnson Services
      • 4.3.1 Johnson & Johnson Services Profiles
      • 4.3.2 Johnson & Johnson Services Product Information
      • 4.3.3 Johnson & Johnson Services Bio-pharma Business Performance
      • 4.3.4 Johnson & Johnson Services Bio-pharma Business Development and Market Status
    • 4.4 Sanofi, Amgen
      • 4.4.1 Sanofi, Amgen Profiles
      • 4.4.2 Sanofi, Amgen Product Information
      • 4.4.3 Sanofi, Amgen Bio-pharma Business Performance
      • 4.4.4 Sanofi, Amgen Bio-pharma Business Development and Market Status
    • 4.5 AbbVie
      • 4.5.1 AbbVie Profiles
      • 4.5.2 AbbVie Product Information
      • 4.5.3 AbbVie Bio-pharma Business Performance
      • 4.5.4 AbbVie Bio-pharma Business Development and Market Status
    • 4.6 Merck & Co., Inc
      • 4.6.1 Merck & Co., Inc Profiles
      • 4.6.2 Merck & Co., Inc Product Information
      • 4.6.3 Merck & Co., Inc Bio-pharma Business Performance
      • 4.6.4 Merck & Co., Inc Bio-pharma Business Development and Market Status
    • 4.7 Biogen Idec
      • 4.7.1 Biogen Idec Profiles
      • 4.7.2 Biogen Idec Product Information
      • 4.7.3 Biogen Idec Bio-pharma Business Performance
      • 4.7.4 Biogen Idec Bio-pharma Business Development and Market Status
    • 4.8 Bayer AG
      • 4.8.1 Bayer AG Profiles
      • 4.8.2 Bayer AG Product Information
      • 4.8.3 Bayer AG Bio-pharma Business Performance
      • 4.8.4 Bayer AG Bio-pharma Business Development and Market Status
    • 4.9 Eli Lilly and Company
      • 4.9.1 Eli Lilly and Company Profiles
      • 4.9.2 Eli Lilly and Company Product Information
      • 4.9.3 Eli Lilly and Company Bio-pharma Business Performance
      • 4.9.4 Eli Lilly and Company Bio-pharma Business Development and Market Status
    • 4.10 Novartis AG GlaxoSmithKline Plc
      • 4.10.1 Novartis AG GlaxoSmithKline Plc Profiles
      • 4.10.2 Novartis AG GlaxoSmithKline Plc Product Information
      • 4.10.3 Novartis AG GlaxoSmithKline Plc Bio-pharma Business Performance
      • 4.10.4 Novartis AG GlaxoSmithKline Plc Bio-pharma Business Development and Market Status
    • 4.11 Bristol-Myers Squibb Company
    • 4.12 AstraZeneca PLC
    • 4.13 Johnson & Johnson Services

    5 Market Performance for Manufacturers

    • 5.1 USA Bio-pharma Sales (K Units) and Market Share by Manufacturers 2013-2018
    • 5.2 USA Bio-pharma Revenue (M USD) and Market Share by Manufacturers 2013-2018
    • 5.3 USA Bio-pharma Price (USD/Unit) of Manufacturers 2013-2018
    • 5.4 USA Bio-pharma Gross Margin of Manufacturers 2013-2018
    • 5.5 Market Concentration

    6 Regions Market Performance for Manufacturers

    • 6.1 Northeast Market Performance for Manufacturers
      • 6.1.1 Northeast Bio-pharma Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.1.2 Northeast Bio-pharma Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.1.3 Northeast Bio-pharma Price (USD/Unit) of Manufacturers 2013-2018
      • 6.1.4 Northeast Bio-pharma Gross Margin of Manufacturers 2013-2018
      • 6.1.5 Market Concentration
    • 6.2 Midwest Market Performance for Manufacturers
      • 6.2.1 Midwest Bio-pharma Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.2.2 Midwest Bio-pharma Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.2.3 Midwest Bio-pharma Price (USD/Unit) of Manufacturers 2013-2018
      • 6.2.4 Midwest Bio-pharma Gross Margin of Manufacturers 2013-2018
      • 6.2.5 Market Concentration
    • 6.3 South Market Performance for Manufacturers
      • 6.3.1 South Bio-pharma Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.3.2 South Bio-pharma Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.3.3 South Bio-pharma Price (USD/Unit) of Manufacturers 2013-2018
      • 6.3.4 South Bio-pharma Gross Margin of Manufacturers 2013-2018
      • 6.3.5 Market Concentration
    • 6.4 West Market Performance for Manufacturers
      • 6.4.1 West Bio-pharma Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.4.2 West Bio-pharma Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.4.3 West Bio-pharma Price (USD/Unit) of Manufacturers 2013-2018
      • 6.4.4 West Bio-pharma Gross Margin of Manufacturers 2013-2018
      • 6.4.5 Market Concentration

    7 USA Bio-pharma Market Performance (Sales Point)

    • 7.1 USA Bio-pharma Sales (K Units) and Market Share by Regions 2013-2018
    • 7.2 USA Bio-pharma Revenue (M USD) and Market Share by Regions 2013-2018
    • 7.3 USA Bio-pharma Price (USD/Unit) by Regions 2013-2018
    • 7.4 USA Bio-pharma Gross Margin by Regions 2013-2018

    8 Development Trend for Regions (Sales Point)

    • 8.1 USA Bio-pharma Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.2 Northeast Bio-pharma Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.3 Midwest Bio-pharma Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.4 South Bio-pharma Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.5 West Bio-pharma Sales and Growth, Sales Value and Growth Rate2013-2018

    9 Upstream Source, Technology and Cost

    • 9.1 Upstream Source
    • 9.2 Technology
    • 9.3 Cost

    10 Channel Analysis

    • 10.1 Market Channel
    • 10.2 Distributors

    11 Consumer Analysis

    • 11.1 Metabolic Disorders Industry
    • 11.2 Oncology Industry
    • 11.3 Neurological Disorders Industry

    12 Market Forecast 2019-2024

    • 12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2019-2024
      • 12.1.1 USA Bio-pharma Sales (K Units), Revenue (M USD) and Market Share by Regions 2019-2024
      • 12.1.2 USA Bio-pharma Sales (K Units) and Growth Rate 2019-2024
      • 12.1.3 Northeast Bio-pharma Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.4 Midwest Bio-pharma Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.5 South Bio-pharma Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.6 West Bio-pharma Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.7 Bio-pharma Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.8 Bio-pharma Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.9 Bio-pharma Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.10 Bio-pharma Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
    • 12.3 Sales (K Units), Revenue (M USD) by Types 2019-2024
      • 12.3.1 Overall Market Performance
      • 12.3.2 Monoclonal Antibodies Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.3.3 Recombinant Proteins Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.3.4 Granulocyte-Colony Stimulating Factor (G-CSF) Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.3.5 Interferons Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
    • 12.4 Sales by Application 2019-2024
      • 12.4.1 Overall Market Performance
      • 12.4.2 Metabolic Disorders Sales and and Growth Rate 2019-2024
      • 12.4.3 Oncology Sales and and Growth Rate 2019-2024
      • 12.4.4 Neurological Disorders Sales and and Growth Rate 2019-2024
      • 12.4.5 Cardiovascular Diseases Sales and and Growth Rate 2019-2024
    • 12.5 Price (USD/Unit) and Gross Profit
      • 12.5.1 USA Bio-pharma Price (USD/Unit) Trend 2019-2024
      • 12.5.2 USA Bio-pharma Gross Profit Trend 2019-2024

    13 Conclusion

    Geographically, this report split USA into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Bio-pharma for these regions, from 2012 to 2023 (forecast), including
    Northeast
    Midwest
    South
    West

    USA Bio-pharma market competition by top manufacturers/players, with Bio-pharma sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Pfizer
    F. Hoffmann-La Roche AG
    Johnson & Johnson Services
    Sanofi, Amgen
    AbbVie
    Merck & Co., Inc
    Biogen Idec
    Bayer AG
    Eli Lilly and Company
    Novartis AG GlaxoSmithKline Plc
    Bristol-Myers Squibb Company
    AstraZeneca PLC
    Abbott Laboratories

    On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
    Monoclonal Antibodies
    Recombinant Proteins
    Granulocyte-Colony Stimulating Factor (G-CSF)
    Interferons
    Recombinant Human Insulin
    Erythropoietin
    Vaccines
    Growth Hormones
    Purified Proteins
    Others

    On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Bio-pharma for each application, including
    Metabolic Disorders
    Oncology
    Neurological Disorders
    Cardiovascular Diseases
    Inflammatory and Infectious Diseases
    Others

    If you have any special requirements, please let us know and we will offer you the report as you want.

    Buy now